Indian pharma firm Eris Lifesciences acquires 51% stake in Swiss Parenterals for Rs 637.5 crore ($76.7m), expanding export market, leveraging Swiss'

Eris Lifesciences, an Indian pharmaceutical company, has acquired a 51% stake in Swiss Parenterals, a sterile injectables firm, for approximately Rs 637.5 crore ($76.7 million). The deal aims to strengthen Eris' India footprint, expand its export market, and leverage Swiss' overseas distribution channels and regulatory expertise. Swiss Parenterals has a strong presence in emerging markets across Africa, Asia Pacific, and Latin America, complementing Eris' focus on India.

February 13, 2024
6 Articles